Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session.
Phase 1/2 clinical trial of MRT-2359 in MYC-driven solid tumors on track; recommended Phase 2 dose expected in Q2 2024 Received US FDA Fast Track Designation for MRT-2359 for previously.
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Get Free Report) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 2,360,000 shares, a decrease of 20.5% from the November 30th total of 2,970,000 shares. Currently, 7.5% of the company’s stock are sold short. Based on […]
Monte Rosa Therapeutics (NASDAQ:GLUE – Get Free Report) and Freeline Therapeutics (NASDAQ:FRLN – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Analyst Ratings This is a breakdown […]